揚宇科技(08113.HK)中期純利升2.89%至1305.9萬港元
格隆匯 8 月 6日丨揚宇科技(08113.HK)公佈,截至2020年6月30日止中期,公司實現收益9.32億港元,同比增長14.66%;公司擁有人應占溢利1305.9萬港元,同比增長2.89%,每股盈利2.00港仙。
公告稱,因應疫情,中國教育部將全國中小學的停課安排延長至2020年5月,在線教學需求隨之上升而平板電腦市場已適應這些需要。第二季度Innolux面板解決方案的銷售額與去年同期相比錄得顯著增長,MID分部仍是集團最大的收益貢獻分部。
隨着2019冠狀病毒病的控制措施逐漸放寬,中國智能手機的銷售隨之在第二季度激增。於回顧期內,公司的新一代面板模組解決方案深受客户歡迎,成為集團第二大收益貢獻分部。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.